The pharmaceutical sector is undergoing a profound transformation as AI and automation move from isolated pilot projects to enterprise-wide adoption. AI is no longer confined to drug discovery or development but is increasingly central to market research, enabling companies to monitor markets, assess competitive landscapes, and understand patient and physician behaviour in real time. By processing massive volumes of scientific literature, digital health data, and real-world evidence (RWE), AI allows insights teams to generate faster, more accurate, and actionable intelligence than traditional workflows. This shift is accelerating the speed and precision of forecasting, pharmacovigilance, and competitive intelligence, fundamentally redefining the purpose, scale, and strategic value of pharmaceutical market research.

Key Highlights:

  • AI-in-pharma market expected to grow from USD 3.8B in 2025 to USD 15.2B by 2030
  • Automation reduces literature review time by 60–80%, allowing analysts to focus on interpretation rather than data gathering
  • AI-driven social listening, transcription analytics, and sentiment analysis provide real-time insights into patient and physician perspectives
  • AI-assisted drug discovery improves Phase I success rates to 80–90%

About The Author

Sagar Gulati Project Lead – Business Intelligence

Sagar is an accomplished insights professional with 3.5 years of experience leading end-to-end market research projects across global FMCG portfolios. His background includes roles at NielsenIQ, Reliance, and Kantar, where he managed high-visibility strategic studies for Fortune 500 clients such as Nestlé, Unilever, Johnson & Johnson, and Coca-Cola India.

He brings deep expertise in product testing, brand health measurement, concept validation, and shopper behaviour research, coupled with strong cross-regional experience working with stakeholders across APAC and Europe. Known for his analytical rigor and client-centric approach, Sagar consistently delivers actionable insights that drive brand and business impact.

Sagar holds a B.Pharm degree and is a registered pharmacist with the Haryana Pharmacy Council, and he completed his MBA in Marketing from ICFAI Mumbai.

Know More
HBG Insights

HBGTM Insights uses cookies and other tracers in order to optimize the performance and functionality of the site, to measure the audience and to adapt the content of the site to your interests. For more information, please refer our Cookie Policy.